Risk Warning: Trading leveraged products such as Forex and CFDs carries a significant level of risk and may not be appropriate for all market participants. The value of derivative instruments can fluctuate rapidly, and losses may exceed initial margin. Institutional and professional clients should ensure they fully understand the risks associated with leveraged products before engaging in any transactions. Past performance is not indicative of future results. A significant proportion of professional client accounts incur losses when trading leveraged products. Prospective clients should ensure they have sufficient expertise and resources to bear the risks of leveraged trading. You should not commit capital that you cannot afford to lose.
Important — No Investor Compensation: Important: Client funds held with Drovix (MU) Ltd are not protected by any government deposit guarantee or investor compensation scheme. The Financial Services Commission (FSC) of Mauritius does not operate an investor compensation fund.
The information on this website is intended for institutional and professional clients only. It does not constitute investment advice, a solicitation, or a recommendation to enter into any transaction. Drovix does not provide services to retail clients.
Reverse Solicitation Notice: The information and services on this website are not directed at or intended for distribution to residents or nationals of any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Institutional clients access Drovix (MU) Ltd services on their own initiative. It is the responsibility of each prospective institutional client to ensure compliance with the laws and regulations of their jurisdiction of incorporation or domicile.
This information is not intended for entities or persons in countries or jurisdictions under significant sanctions, including but not limited to Afghanistan, Barbados, Belarus, Burkina Faso, Cameroon, Central African Republic, Cuba, Democratic Republic of Congo, Haiti, Iran, Libya, Mali, Mozambique, Myanmar, Nicaragua, North Korea, Russia, Senegal, Sudan, Syria, Tanzania, Venezuela, Yemen, and Zimbabwe.
All information, products, and services offered on the Drovix website are not intended for entities or persons in Australia, Belgium, Canada, France, Japan, Malaysia, Poland, Ukraine, the United Kingdom, or the United States. The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. Drovix services are available exclusively to eligible institutional and professional clients.
